(S)-叔丁氧羰基-3-(3-吡啶基)-β-丙氨酸 | 297773-45-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: (S)-叔丁氧羰基-3-(3-吡啶基)-β-丙氨酸
• 中文别名: (S)-N-Boc-3-(3-吡啶)-beta-丙胺酸；(S)-3-(BOC-氨基)-3-(3-吡啶基)丙酸；S)-叔丁氧羰基-3-(3-吡啶基)-Beta-丙氨酸；(S)-叔丁氧羰基-3-(3-吡啶基)-Beta-丙氨酸
• 英文名称: (S)-3-[(tert-butoxy)carbonyl]amino-3-(3'-pyridyl)propionic acid
• 英文别名: (3S)-3-[(tert-butoxy)carbonyl]amino-3-[3'-pyridyl]propionic acid；(S)-3-(tert-butoxycarbonylamino)-3-(pyridin-3-yl)propanoic acid；Boc-(s)-3-amino-3-(3-pyridyl)-propionic acid；(3S)-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridin-3-ylpropanoic acid
• CAS: 297773-45-6
• 化学式: C₁₃H₁₈N₂O₄
• 分子量: 266.297
• InChiKey: GQWRNLFTLLZYBJ-JTQLQIEISA-N

物化性质

• 稳定性/保质期：
  常温常压下稳定，应避免与强氧化剂接触。

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  19
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  88.5
• 氢给体数：
  2
• 氢受体数：
  5

安全信息

• WGK Germany：
  3
• 海关编码：
  2933399090

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
: (S)-Boc-3-(3-pyridyl)-β-Ala-OH
Product name
CAS-No. : 297773-45-6
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a dangerous substance according to GHS.
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
Caution - substance not yet tested completely.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
: D-Boc-3-(3-pyridyl)-β-alanine
Synonyms
(S)-3-(Boc-amino)-3-(3-pyridyl)propionic acid
Formula : C13H18N2O4
Molecular Weight : 266,29 g/mol
Component Concentration
(S)-Boc-3-(3-pyridyl)-beta -Ala-OH
CAS-No. 297773-45-6 -

---

Section 4. FIRST AID MEASURES
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
Indication of immediate medical attention and special treatment needed
no data available

---

Section 5. FIRE-FIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Precautions for fire-fighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Avoid dust formation. Avoid breathing vapors, mist or gas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the
standard EN 374 derived from it.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting/freezing point 141 °C
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN-Number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for users
no data available

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

---

Section 16. OTHER INFORMATION
Further information
Copyright 2011 Co. License granted to make unlimited paper copies for internal use only.
The above information is believed to be correct but does not purport to be all inclusive and shall be used
only as a guide. The information in this document is based on the present state of our knowledge and is
applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Co., shall not be held liable for any damage
resulting from handling or from contact with the above product. See reverse side of invoice or packing slip
for additional terms and conditions of sale.

反应信息

• 作为反应物：
  描述：

  (S)-叔丁氧羰基-3-(3-吡啶基)-β-丙氨酸 在 4-二甲氨基吡啶 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 二氯甲烷 、 乙酸乙酯 为溶剂， 生成
  参考文献：
  名称：

  高效，选择性和口服可生物利用的富含亮氨酸的重复激酶2（LRRK2）抑制剂

  摘要：

  最近，家族性帕金森氏病病例与富含亮氨酸的重复激酶2（LRRK2）基因有关。已经假设LRRK2蛋白的抑制可能具有改变疾病发病机理的潜力。从内部默克样品收集的高通量筛选中鉴定出了有效的，选择性的，口服生物利用的LRRK2抑制剂的二氢苯并噻吩系列。最初围绕核心进行的SAR研究将该系列确立为可治疗帕金森氏病的LRRK2抑制剂的易处理小分子先导系列。还发现将内酰胺掺入核心中大大改善了这些小分子的CNS和DMPK特性。

  DOI：

  10.1016/j.bmcl.2016.04.021
• 作为产物：
  描述：

  (S)-3-[(tert-butoxy)carbonyl]amino-3-(3'-pyridyl)propionic acid (1R,2S)-(-)-ephedrine salt 在 sodium hydroxide 作用下， 以 水 为溶剂， 以72%的产率得到(S)-叔丁氧羰基-3-(3-吡啶基)-β-丙氨酸
  参考文献：
  名称：

  一种拆分3-氨基-3-(3'-吡啶基)丙酸及相关化合物的简便方法

  摘要：

  通过羧酸前体（N-BOC-保护）与 (1R,2S) 的非对映体盐的选择性结晶制备高对映体纯度的 (S)-3-氨基-3-(3'-吡啶基)丙酸甲酯二盐酸盐描述了-(-)-麻黄碱。还描述了该程序在拆分其他 3-氨基-3-[（取代）吡啶基]丙酸方面的有用性的进一步证明。

  DOI：

  10.1021/op990192m

文献信息

• Renin inhibitors
  申请人：Takeda Pharmaceutical Company Limited

  公开号：US08138168B1

  公开（公告）日：2012-03-20

  The invention relates to compounds having the formulae: wherein the variables are as defined herein. The invention further relates to methods of making and using these compounds, and pharmaceutical compositions, kits and articles of manufacture comprise the compounds.

  这项发明涉及具有以下式的化合物： 其中变量如本文所定义。该发明还涉及制备和使用这些化合物的方法，以及包含这些化合物的药物组合物、试剂盒和制造物品。
• Conformationally restricted analogs of deoxynegamycin
  作者：B. Raju、Sampathkumar Anandan、Shihai Gu、Prudencio Herradura、Hardwin O’Dowd、Bum Kim、Marcela Gomez、Corinne Hackbarth、Charlotte Wu、Wen Wang、Zhengyu Yuan、Richard White、Joaquim Trias、Dinesh V. Patel

  DOI：10.1016/j.bmcl.2004.04.036

  日期：2004.6

  Deoxynegamycin (1b) is a protein synthesis inhibitor with activity against Gram-negative (GN) bacteria. A series of conformationally restricted analogs were synthesized to probe its bioactive conformation. Indeed, some of the constrained analogs were found to be equal or better than deoxynegamycin in protein synthesis assay (1b, IC(50)=8.2 microM; 44, IC(50)=6.6 microM; 35e(2), IC(50)=1 microM). However

  脱氧霉素（1b）是一种蛋白质合成抑制剂，对革兰氏阴性（GN）细菌具有活性。合成了一系列构象受限的类似物以探测其生物活性构象。确实，在蛋白质合成测定中发现某些受约束的类似物与脱氧新霉素相同或更好（1b，IC（50）= 8.2 microM; 44，IC（50）= 6.6 microM; 35e（2），IC（50） = 1微米）。然而，脱氧新霉素在体外具有最佳的全细胞抗菌活性（大肠杆菌，MIC = 4-16 microg / mL；肺炎克雷伯菌，MIC = 8 microg / mL），这表明其他因素（例如渗透）也可能对整体有贡献。细胞活性。一个新发现是，脱氧新霉素在大肠杆菌鼠类败血病模型中有效（ED（50）= 4.8 mg / kg），
• Process of preparing 3S-3-amino-3-aryl proprionic acid and derivatives thereof
  申请人：——

  公开号：US20020068829A1

  公开（公告）日：2002-06-06

  The present invention is directed to a process for preparing 3S-3-amino-3-aryl propionic acid and derivatives thereof.

  本发明涉及一种制备3S-3-氨基-3-芳基丙酸及其衍生物的方法。
• Process of preparing 3S-3-amino-3-aryl propionic acid and derivatives thereof
  申请人：——

  公开号：US20040063960A1

  公开（公告）日：2004-04-01

  The present invention is directed to a process for preparing 3S-3-amino-3-aryl propionic acid and derivatives thereof.

  本发明涉及一种制备3S-3-氨基-3-芳基丙酸及其衍生物的过程。
• Process of preparing 3S-3-amino-3aryl propionic acid and derivatives thereof
  申请人：——

  公开号：US20030176471A1

  公开（公告）日：2003-09-18

  The present invention is directed to a process for preparing 3S-3-amino-3-aryl propionic acid and derivatives thereof.

  本发明涉及一种制备3S-3-氨基-3-芳基丙酸及其衍生物的方法。